Trials / NCT02588430
PMCF Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS
Withdrawn Observational Natural history / observational
Why it stopped: Manufacturer of the investigational device has ceased all business activities
- Sponsor
- Retina Implant AG
- Treatment
- Not listed
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to no upper limit
- Enrollment
- Not stated participants
- Started
- 2019-03
- Main results expected
- 2029-12
- Results posted
- Not yet
- Record last updated
- 2019-04-19
What the study is testing
This study is a post-market clinical follow-up (PMCF) study to monitor the safety, lifetime and efficacy of patients using the CE-certified RETINA IMPLANT Alpha AMS.
Where it runs
Germany (1)
- Katharinenhospital Stuttgart, Stuttgart